I am surprised no one responded to this post by @eyedrop. This part got me thinking.
Giving the current s.p. of MSB, downside is less risky than the upside. You may lose 100% if MSB's s.p. down to zero, but you may get 100% gain if its s.p. back to $2,30 as on three months ago.
I.m.o., giving to its leading position in the world on its fields, the worst scenario would be taken over by other party, giving its MC is now only A$442M (USD$300M).
That suggests the MSB is close to the value of the technology and families of patients.
Therefore, buying MSB at current prices means relatively little risk on the down side but great potential upside.
That makes MSB the best bet on the ASX, IMO.
If MSB is to be removed from S&P ASX 200...., page-242
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |